54 related articles for article (PubMed ID: 1140513)
1. Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon.
Chiasson JL; Liljenquist JE; Sinclair-Smith BC; Lacy WW
Diabetes; 1975 Jun; 24(6):574-84. PubMed ID: 1140513
[TBL] [Abstract][Full Text] [Related]
2. Gluconeogenesis in frogs during cooling and dehydration exposure: new insights into tissue plasticity of the gluconeogenic pathway dependent on abiotic factors.
de Amaral M; Von Dentz MC; David SM; Kucharski LC
J Exp Biol; 2024 Jun; 227(11):. PubMed ID: 38774939
[TBL] [Abstract][Full Text] [Related]
3. Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence.
McGlone ER; Bloom SR; Tan TM
J Endocrinol; 2024 Jun; 261(3):. PubMed ID: 38579751
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells.
Elmelund E; Galsgaard KD; Johansen CD; Trammell SAJ; Bomholt AB; Winther-Sørensen M; Hunt JE; Sørensen CM; Kruse T; Lau JF; Grevengoed TJ; Holst JJ; Wewer Albrechtsen NJ
iScience; 2022 Nov; 25(11):105296. PubMed ID: 36325048
[TBL] [Abstract][Full Text] [Related]
5. Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.
Soto-Mota A; Norwitz NG; Evans RD; Clarke K
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00300. PubMed ID: 34787952
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of glucagon in humans.
Adeva-Andany MM; Funcasta-Calderón R; Fernández-Fernández C; Castro-Quintela E; Carneiro-Freire N
J Clin Transl Endocrinol; 2019 Mar; 15():45-53. PubMed ID: 30619718
[TBL] [Abstract][Full Text] [Related]
7. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
8. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
Roden M; Perseghin G; Petersen KF; Hwang JH; Cline GW; Gerow K; Rothman DL; Shulman GI
J Clin Invest; 1996 Feb; 97(3):642-8. PubMed ID: 8609218
[TBL] [Abstract][Full Text] [Related]
9. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man.
Nurjhan N; Bucci A; Perriello G; Stumvoll M; Dailey G; Bier DM; Toft I; Jenssen TG; Gerich JE
J Clin Invest; 1995 Jan; 95(1):272-7. PubMed ID: 7814625
[TBL] [Abstract][Full Text] [Related]
10. Effect of injury and infection on visceral metabolism and circulation.
Wilmore DW; Goodwin CW; Aulick LH; Powanda MC; Mason AD; Pruitt BA
Ann Surg; 1980; 192(4):491-504. PubMed ID: 7425696
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans.
Wells PG; Moore GW; Rabin D; Wilkinson GR; Oates JA; Stacpoole PW
Diabetologia; 1980 Aug; 19(2):109-13. PubMed ID: 7418965
[TBL] [Abstract][Full Text] [Related]
12. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.
Owen OE; Reichle FA; Mozzoli MA; Kreulen T; Patel MS; Elfenbein IB; Golsorkhi M; Chang KH; Rao NS; Sue HS; Boden G
J Clin Invest; 1981 Jul; 68(1):240-52. PubMed ID: 7251861
[TBL] [Abstract][Full Text] [Related]
13. Influence of hyperthyroidism on splanchnic exchange of glucose and gluconeogenic precursors.
Wahren J; Wennlund A; Nilsson LH; Felig P
J Clin Invest; 1981 Apr; 67(4):1056-63. PubMed ID: 7204566
[TBL] [Abstract][Full Text] [Related]
14. Hormonal changes and their influence on metabolism and nutrition in the critically ill.
Dahn MS; Lange P
Intensive Care Med; 1982; 8(5):209-13. PubMed ID: 6752238
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and renal metabolism before and after portasystemic shunts in patients with cirrhosis.
Owen OE; Mozzoli MA; Reichle FA; Kreulen TH; Owen RS; Boden G; Polansky M
J Clin Invest; 1985 Sep; 76(3):1209-17. PubMed ID: 4044831
[TBL] [Abstract][Full Text] [Related]
16. Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog.
Stevenson RW; Williams PE; Cherrington AD
Diabetologia; 1987 Oct; 30(10):782-90. PubMed ID: 3322904
[TBL] [Abstract][Full Text] [Related]
17. The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs.
Freyse EJ; Fischer U; Albrecht G; Marx S; Keilacker H
Diabetologia; 1987 Jun; 30(6):402-8. PubMed ID: 3315797
[TBL] [Abstract][Full Text] [Related]
18. Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog.
Adkins BA; Myers SR; Hendrick GK; Stevenson RW; Williams PE; Cherrington AD
J Clin Invest; 1987 Feb; 79(2):557-65. PubMed ID: 2879854
[TBL] [Abstract][Full Text] [Related]
19. Glucagon in the metabolic and nutritional management after total pancreatectomy--a case report.
Hirota M; Ikei S; Mishima M; Mori K; Sakamoto K; Yamane T; Idegami K; Katafuchi S; Kiyohara H; Nakashima Y
Jpn J Surg; 1989 Sep; 19(5):586-92. PubMed ID: 2687529
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
